These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17525974)

  • 1. Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study.
    van Winkel R; Henquet C; Rosa A; Papiol S; Fananás L; De Hert M; Peuskens J; van Os J; Myin-Germeys I
    Am J Med Genet B Neuropsychiatr Genet; 2008 Jan; 147B(1):10-7. PubMed ID: 17525974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COMT Val158Met-stress interaction in psychosis: role of background psychosis risk.
    Collip D; van Winkel R; Peerbooms O; Lataster T; Thewissen V; Lardinois M; Drukker M; Rutten BP; Van Os J; Myin-Germeys I
    CNS Neurosci Ther; 2011 Dec; 17(6):612-9. PubMed ID: 21073668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val¹⁵⁸Met polymorphism.
    Vinkers CH; Van Gastel WA; Schubart CD; Van Eijk KR; Luykx JJ; Van Winkel R; Joëls M; Ophoff RA; Boks MP; ; Bruggeman R; Cahn W; de Haan L; Kahn RS; Meijer CJ; Myin-Germeys I; van Os J; Wiersma D
    Schizophr Res; 2013 Oct; 150(1):303-11. PubMed ID: 23954148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that interactive effects of COMT and MTHFR moderate psychotic response to environmental stress.
    Peerbooms O; Rutten BP; Collip D; Lardinois M; Lataster T; Thewissen V; Rad SM; Drukker M; Kenis G; van Os J; Myin-Germeys I; van Winkel R
    Acta Psychiatr Scand; 2012 Mar; 125(3):247-56. PubMed ID: 22128864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism.
    Estrada G; Fatjó-Vilas M; Muñoz MJ; Pulido G; Miñano MJ; Toledo E; Illa JM; Martín M; Miralles ML; Miret S; Campanera S; Bernabeu C; Navarro ME; Fañanás L
    Acta Psychiatr Scand; 2011 Jun; 123(6):485-92. PubMed ID: 21231925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catechol-O-methyltransferase Val158Met polymorphism and clinical characteristics in first episode non-affective psychosis.
    Pelayo-Terán JM; Crespo-Facorro B; Carrasco-Marín E; Pérez-Iglesias R; Mata I; Arranz MJ; Leyva-Cobián F; Vázquez-Barquero JL
    Am J Med Genet B Neuropsychiatr Genet; 2008 Jul; 147B(5):550-6. PubMed ID: 18092319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that the COMTVal158Met polymorphism moderates subclinical psychotic and affective symptoms in unaffected first-degree relatives of patients with schizophrenia.
    van Winkel R; Isusi P; Galdos P; Echevarria E; Bilbao JR; Martin-Pagola A; Castaño L; Papiol S; Mengelers R; Krabbendam L; van Os J; Myin-Germeys I
    Eur Psychiatry; 2008 Apr; 23(3):219-22. PubMed ID: 18328676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life.
    Henquet C; Rosa A; Delespaul P; Papiol S; Fananás L; van Os J; Myin-Germeys I
    Acta Psychiatr Scand; 2009 Feb; 119(2):156-60. PubMed ID: 18808401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COMT Val158Met moderation of stress-induced psychosis.
    Stefanis NC; Henquet C; Avramopoulos D; Smyrnis N; Evdokimidis I; Myin-Germeys I; Stefanis CN; Van Os J
    Psychol Med; 2007 Nov; 37(11):1651-6. PubMed ID: 17640440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis, COMT and psychotic experiences.
    Zammit S; Owen MJ; Evans J; Heron J; Lewis G
    Br J Psychiatry; 2011 Nov; 199(5):380-5. PubMed ID: 21947654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between cannabis use and the Val158Met polymorphism of the COMT gene in psychosis: A transdiagnostic meta - analysis.
    Vaessen TSJ; de Jong L; Schäfer AT; Damen T; Uittenboogaard A; Krolinski P; Nwosu CV; Pinckaers FME; Rotee ILM; Smeets APW; Ermiş A; Kennedy JL; Nieman DH; Tiwari A; van Os J; Drukker M
    PLoS One; 2018; 13(2):e0192658. PubMed ID: 29444152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosis.
    Mata I; Perez-Iglesias R; Pelayo-Teran JM; Rodríguez-Sanchez JM; Gonzalez-Blanch C; Carrasco-Marin E; Vazquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2008 Jul; 102(1-3):206-9. PubMed ID: 18407467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.
    Henquet C; Rosa A; Krabbendam L; Papiol S; Fananás L; Drukker M; Ramaekers JG; van Os J
    Neuropsychopharmacology; 2006 Dec; 31(12):2748-57. PubMed ID: 16936704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications.
    Pelayo-Terán JM; Pérez-Iglesias R; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
    Psychiatry Res; 2010 Oct; 179(3):291-6. PubMed ID: 20493536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosis.
    Pelayo-Terán JM; Pérez-Iglesias R; Vázquez-Bourgon J; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
    Psychiatry Res; 2011 Jan; 185(1-2):286-9. PubMed ID: 20591499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COMT Val(158)Met genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions.
    Nieman DH; Dragt S; van Duin EDA; Denneman N; Overbeek JM; de Haan L; Rietdijk J; Ising HK; Klaassen RMC; van Amelsvoort T; Wunderink L; van der Gaag M; Linszen DH
    Schizophr Res; 2016 Jul; 174(1-3):24-28. PubMed ID: 27052366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the COMT-Val158Met and BDNF-Val66Met polymorphisms, childhood trauma and psychotic experiences in an adolescent general population sample.
    Ramsay H; Kelleher I; Flannery P; Clarke MC; Lynch F; Harley M; Connor D; Fitzpatrick C; Morris DW; Cannon M
    PLoS One; 2013; 8(11):e79741. PubMed ID: 24224001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
    Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
    J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-dependent association of the functional catechol-O-methyltransferase Val158Met genotype with sensation seeking personality trait.
    Lang UE; Bajbouj M; Sander T; Gallinat J
    Neuropsychopharmacology; 2007 Sep; 32(9):1950-5. PubMed ID: 17299513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [COMT Val158Met polymorphism and schizophrenia in a series of Spanish patients].
    Díez-Martín J; Hoenicka J; Martínez I; Aragüés M; Rodríguez-Jiménez R; Jiménez-Arriero MA; Ponce G; Rubio G; Palomo T;
    Med Clin (Barc); 2007 Jan; 128(2):41-4. PubMed ID: 17266899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.